• <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 發布時間:2019-04-21 16:12 原文鏈接: RNaseandDEPCTreatment:FactorLaboratoryMyth

    Researchers are usually trained in RNA isolation and analysis methods by one another or by technical manuals. Experimental procedures are often not questioned and quickly become dogma. Furthermore, it is difficult to find literature to document the "facts" taught by mentors and technical manuals. One of these potential myths is the use of DEPC treatment to make solutions RNase-free. At Ambion, we have systematically investigated some of the DEPC fables, and the results are discussed below. Watch upcoming issues of TechNotes in which Ambion will put other RNA "truths" to the test.

    1. Autoclaving is not effective at eliminating RNase in solution because the RNases simply renature as the solution cools.

    FALSE, but... Autoclaving alone does indeed inactivate a substantial amount of RNase A (Figure 1). Various concentrations of RNase A were added to PBS and autoclaved. Aliquots of each solution were mixed with a 304 base 32P-labeled RNA probe and incubated at 37°C for one hour, followed by electrophoresis and exposure to film. Without autoclaving, the probe begins to degrade at an RNase concentration of 100 pg/ml. Autoclaving inactivates enough of the RNase A to protect the probe from degradation up to a concentration of 1 μg/ml. Note that only a portion of the RNase is inactivated by autoclaving, otherwise the RNA probe would remain intact at any RNase concentration. Autoclaving alone may be sufficient to eliminate enough RNase for some applications. However, since neither the extent of RNase contamination nor at what RNase concentration the assay is sensitive is known, DEPC should be used as an added precaution. Also note that these experiments were only performed on RNase A and may not hold true for other RNases.

    Figure 1. Effect of Autoclaving on RNase Activity. Various concentrations of RNase A were added to PBS and autoclaved for 25 minutes. 1 μl of each solution was mixed with 1 ng of a 5 x 104cpm RNA probe which was 304 bases long and incubated at 37°C for one hour. 5 μl of the reaction was assessed on a 5% acrylamide/8 M urea gel and exposed to film for 5 hours with an intensifying screen.


    2. Autoclaving inactivates DEPC.

    TRUE. Autoclaving does inactivate DEPC by causing hydrolysis of diethylpyrocarbonate. CO2 and EtOH are released as reaction by-products. DEPC has a half-life of approximately 30 minutes in water, and at a DEPC concentration of 0.1%, solutions autoclaved for 15 minutes/liter can be assumed to be DEPC-free.

    3. Autoclaving DEPC-containing solutions should be of sufficient duration to rid the solution of any smell.

    FALSE. A faint EtOH smell may linger after autoclaving, but more commonly a sweet, fruity smell is observed. This is caused by the EtOH by-product combining with trace carboxylic acid contaminates and forming volatile esters. It does not mean that trace DEPC remains in the solution.

    4. Solutions containing Tris cannot be treated with DEPC.

    TRUE. Tris contains an amino group which "sops up" DEPC and makes it unavailable to inactivate RNase (Figure 2). 1 M solutions of Tris, MOPS, HEPES and PBS were prepared, and 0.1% or 1% DEPC was added to each. One μg/ml RNase A was also added to each solution. The solutions were autoclaved and aliquots of each solution were mixed with a 304 base 32P-labeled RNA probe and incubated at 37°C for one hour. Probe integrity was assessed by electrophoresis and exposure to film. Tris and HEPES do indeed make DEPC unavailable to inactivate RNase at a DEPC concentration of 0.1% (recommended by most protocols). However, 1% DEPC is sufficient to overcome this effect. When 1M MOPS and PBS are treated with DEPC, the DEPC remains available to inactive RNase at both concentrations (0.1% and 1%). It would be impossible to predict the different interactions of DEPC with all molecular biology reagents. The most cautious approach for making RNase-free solutions would be to mix molecular biology grade powdered reagents up in DEPC-treated water. Alternatively, many pre-made nuclease-free solutions can be purchased from Ambion and other companies.

    Figure 2. Effects of DEPC Treatment of Various Buffers. One μg/ml RNase A was added to various buffers along with 0.1% or 1% DEPC. Solutions were vigorously shaken for 1 minute, incubated for 1 hour at room temperature and autoclaved for 25 minutes. 1 μl of each solution was mixed with 1 ng of a 5 x 104 cpm 304 nt RNA probe and incubated at 37°C for one hour. 5 μl of the reaction was assessed on a 5% acrylamide/8 M urea gel and exposed overnight to film.




    5. 0.1% DEPC is sufficient to inhibit any amount of RNase in a solution.

    FALSE, but... The amount of DEPC required to inactivate RNase increases as the amount of contaminating RNase in a solution increases (Figure 3). 100, 500, and 1000 ng/ml RNase A was added to water followed by various amounts of DEPC. The solutions were autoclaved, and aliquots of each solution were mixed with a 304 base 32P labeled RNA probe and incubated at 37°C for one hour followed by electrophoresis and exposure to film. Untreated solutions or those treated with 0.01% DEPC could inactivate 100 ng/ml RNase A. When the RNase concentration was increased to 500 ng/ml, the DEPC concentration was insufficient to inactivate the RNase, and the probe degraded. Increasing the DEPC concentration to 0.1% protects the probe from RNase A up to 500 ng/ml and a 1% DEPC solution inactivates RNase A at a concentration of 1000 ng/ml. 0.1% DEPC is probably adequate to inactivate most RNase contamination from environmental sources and from laboratory procedures such as ribonuclease protection assays and plasmid preparations in which larger amounts of RNase are used.


    Figure 3. Effects of Varying Percentages of DEPC on Increasing Concentrations of RNase. Various concentrations of RNase A were added to aliquots of water, shaken vigorously for one minute, incubated for one hour at room temperature and autoclaved for 25 minutes. 1 μl of each solution was mixed with 1 ng of a 5 x 104 cpm RNA 304 nt probe and incubated at 37°C for one hour. 5 μl of the reaction was assessed on a 5% acrylamide/8 M urea gel and exposed overnight to film.


    6. If 0.1% DEPC works well to inhibit RNase, 1% should work even better.

    TRUE, but... Increasing DEPC concentrations inactivate increasing amounts of RNase A contamination (Figure 3). However, it is also true that high levels of residual DEPC or DEPC by-products in a solution can inhibit some enzymatic reactions or chemically alter (carboxymethylate) RNA. It has been documented that DEPC byproducts in RNA samples can inhibit in vitro translation reactions (Winkler, unpublished results). For this study, we tested transcription reactions for DEPC inhibition effects. Template DNA was dried to completion in a vacuum centrifuge and resuspended in 0.01%, 0.1% or 1% DEPC-treated water. Duplicate MAXIscript? transcription reactions were assembled using 32P-UTP, and the same concentration of DEPC treated water bought up the volume. The reactions were incubated and percent incorporation was assessed via TCA precipitation. The average percent incorporation were as follows:


    % DEPC in reaction

    % incorporation

    0.01

    64

    0.10

    59

    1.00

    53


    The above data indicate that increasing amounts of DEPC increasingly inhibit transcription. Again, 0.1% DEPC is probably sufficient to inhibit most RNases with minimal effect on reactions. If DEPC is suspect in inhibiting reactions, high quality (MilliQì) or autoclaved water can probably be substituted into the reaction. Water can be tested using Ambion's RNaseAlert? Kit or see Ambion's Technical Bulletin #166, Nuclease and Protease Testing: Laboratory and Commercial Considerations, which describes an RNase testing protocol similar to that used in this study.

    Related Articles

    How to Maintain an RNase-free Lab 

    RNase Control: The Basics 

    Top Ten Sources of RNase Contamination 


    Ordering Information

    Cat#Product NameSize
    4387936Nuclease-free Water (not DEPC-treated)4 x 1 L
    4387937DEPC-treated Water4 x 1 L
    AM1964RNaseAlert? Lab Test Kit25 rxns
    AM1966RNaseAlert? QC System5 x 96 assays
    AM9780RNaseZap?250 ml
    AM9782RNaseZap?6 x 250 ml
    AM9784RNaseZap?4 L
    AM9786RNaseZap? Wipes1 container (100 sheets)
    AM9788RNaseZap? Wipes Refill3 x 100 sheets
    AM9906DEPC-treated Water10 x 50 ml
    AM9915GDEPC Treated Water100 ml
    AM9916DEPC-treated Water5 x 100 ml
    AM9920DEPC-treated Water500 ml
    AM9922DEPC-treated Water1 L
    AM9930Nuclease-free Water (not DEPC-treated)500 ml
    AM9932Nuclease-free Water (not DEPC-treated)1 L
    AM9937Nuclease-free Water (not DEPC-treated)10 x 50 ml
    AM9938Nuclease-free Water (not DEPC-treated)100 ml
    AM9939Nuclease-free Water (not DEPC-treated)5 x 100 ml


    相關文章

    Nature:研究者揭示FACT蛋白操縱核小體機制

    眾所周知,包裝DNA的組蛋白(H2A、H2B、H3和H4)需要分子伴侶。FACT(FacilitatesChromatinTranscription)蛋白是一類至關重要的組蛋白伴侶(histonech......

    腫瘤治療的強心劑,中國學者開發腫瘤治療新策略

    磷酸甘油酸突變酶1(PGAM1)通過其代謝活性以及與其他蛋白質(例如α平滑肌肌動蛋白(ACTA2))的相互作用,在癌癥代謝和腫瘤進展中起關鍵作用。變構調節被認為是發現針對PGAM1的高選擇性和有效抑制......

    研究發現染轉錄輔助因子FACT的獨特雙重功能

    兩句耳熟能詳的俗語“龍生龍,鳳生鳳”和“龍生九子各不相同”道出了生物遺傳現象中兩個關鍵的特點:相似性和特異性。人類基因組精確測序顯示人類基因的差異很小(<0.3%),這解釋了遺傳相似性的來源;另......

    古老的RNaseIII抗病毒防御系統有望引發RNA治療變革

    盡管人類主要依賴更加復雜的更加強大的抗病毒防御系統,但是早期的生命形式在十億年前形成的讓它們自己抵抗病毒感染的原始防御系統仍然能夠在人細胞中發現到。如果科學家們能夠設計出有益的病毒,讓這些病毒利用這種......

    LabCorp公司以61億美元收購Covance坐享其海外業務

    北京時間11月3日晚間,醫療診斷服務提供商LaboratoryCorp表示,將斥資約61億美元現金及股票購并合約研究公司Covance。LaboratoryCorp此次收購是來自制藥公司對其診斷業務償......

  • <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 调性视频